Pharmacogenomic characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers

ABSTRACT: MI-773 is a recently developed small-molecule inhibitor of the Mouse Double Minute 2 (MDM2) proto-oncogene. Here we report an integrative pharmacogenomic study to gain further insights into the therapeutic potential of the compound.

ORGANISM(S): Homo sapiens

PROVIDER: GSE152529 | GEO | 2021/10/27

REPOSITORIES: GEO